BCL2 and neoplasm: Since the mithramycin/TNF combination is capable of inducing apoptosis in TF-1 cells independently of the mitochondrial pathway, combining TNF treatment with mithramycin could have potential for elimination of tumour cells that express large amounts of Bcl-2.